Caxton Associates (UK)’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,938	Closed	-$170K	–	947
2025 Q1	$170K	Buy	+30,938	New	+$170K	0.01%	712